| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Revenue | $3.2B | $3.5B | $3.1B |
| Cost of Revenue | — | — | — |
| Gross Profit | — | — | — |
| R&D Expense | — | — | — |
| SG&A Expense | $0.8B | $0.8B | $0.7B |
| Operating Income | $0.2B | $0.6B | $-0.3B |
| Net Income | $-0.1B | $0.3B | $-0.3B |
| EPS (Basic) | $-1.61 | $4.72 | $-4.46 |
| EPS (Diluted) | $-1.61 | $4.69 | $-4.46 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Total Assets | $5.9B | $5.9B | $6.1B |
| Current Assets | $1.7B | $1.5B | $1.5B |
| Cash & Equivalents | $0.9B | $0.7B | $0.7B |
| Total Liabilities | $5.6B | $5.4B | $5.9B |
| Current Liabilities | $0.7B | $0.6B | $1.1B |
| Stockholders' Equity | $0.4B | $0.6B | $0.3B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ |
|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.1B | $0.2B |
| Investing Cash Flow | $-0.1B | $0.1B | $0.1B |
| Capital Expenditures | $0.1B | $0.1B | $0.1B |
| Financing Cash Flow | $0.1B | $-0.1B | $-0.5B |